Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells (Q44414175)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2, 2003

Language	Label	Description	Also known as
English	Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells	scientific article published on May 2, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells (English)

1 reference

Europe PubMed Central

2 December 2017

Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells (English)

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

author name string

Petra Augstein

1

1 reference

Europe PubMed Central

2 December 2017

Annemarie Dunger

2

1 reference

Europe PubMed Central

2 December 2017

Peter Heinke

3

1 reference

Europe PubMed Central

2 December 2017

Gerhild Wachlin

4

1 reference

Europe PubMed Central

2 December 2017

Sabine Berg

5

1 reference

Europe PubMed Central

2 December 2017

Bernd Hehmke

6

1 reference

Europe PubMed Central

2 December 2017

Eckhard Salzsieder

7

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

2 December 2017

2 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12711326

27 December 2023

full work available at URL

https://api.elsevier.com/content/article/PII:S0006291X03005904?httpAccept=text/xml

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

https://api.elsevier.com/content/article/PII:S0006291X03005904?httpAccept=text/plain

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

2 December 2017

304

1 reference

Europe PubMed Central

2 December 2017

2

1 reference

Europe PubMed Central

2 December 2017

378-384

1 reference

Europe PubMed Central

2 December 2017

Discovery of ligands for the nuclear peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR(gamma) and glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Novel insulin sensitizers: pharmacogenomic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Thiazolidinediones: metabolic actions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Peroxisome proliferator-activated receptors in inflammation control

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Inflammatory status and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR agonists as direct modulators of the vessel wall in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Inflammation and the development of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR and immune system--what do we know?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Troglitazone exhibits immunomodulatory activity on the cytokine production of activated human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Benign versus destructive insulitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Cellular and molecular changes accompanying the progression from insulitis to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Detection of islet cell specificity of monoclonal islet cell surface antibodies by means of double-staining immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Immunoadsorption of immunoglobulins alters intracytoplasmic type 1 and type 2 T cell cytokine production in patients with refractory autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Control of islet intercellular adhesion molecule-1 expression by interferon-alpha and hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

The immunological synapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

The immunological synapse: integrins take the stage.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

A key role for ICAM-1 in generating effector cells mediating inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Cellular and molecular roles of beta cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Oral DNA vaccination with a plasmid encoding soluble ICAM-1 modulates cytokine expression profiles in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Macrophages and antioxidant status in the NOD mouse pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage-derived cytokines in a model of organ-specific insulitis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Myocardial cell death in human diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Avidity regulation of integrins: the driving force in leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Multiple immuno-regulatory defects in type-1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Suppressor T cells--they're back and critical for regulation of autoimmunity!

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Th1 and Th2 cytokines exert regulatory effects upon islet microvascular areas in the NOD mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Insulin therapy of prediabetes suppresses TH1 associated gene expression in BB rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Diabetes research (Edinburgh, Scotland)

39

3

13

author name string

Hehmke

publication date

1986

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

44

42

A156

author name string

Fischer

publication date

1999

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

60

41

A160

author name string

Dunger

publication date

1998

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

Identifiers

10.1016/S0006-291X(03)00590-4

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44414175&oldid=2037961750"